Secretome signature of invasive glioblastoma multiforme - Wikidata - wikimedia - TriplyDB

Secretome signature of invasive glioblastoma multiforme

Secretome signature of invasive glioblastoma multiforme

http://www.wikidata.org/entity/Q33901250

about

Chitinase-3-like-1/YKL-40 as marker of circulating tumor cells Dose-dependent activation of putative oncogene SBSN by BORIS Suprabasin is hypomethylated and associated with metastasis in salivary adenoid cystic carcinoma.Secreted proteins from carotid endarterectomy: an untargeted approach to disclose molecular clues of plaque progression Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration.Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells.CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours.Multi-study integration of brain cancer transcriptomes reveals organ-level molecular signatures Suprabasin as a novel tumor endothelial cell marker.High level of Sema3C is associated with glioma malignancy.Quantitative proteomics reveals an altered cystic fibrosis in vitro bronchial epithelial secretome Secretome survey of human plexiform neurofibroma derived Schwann Cells reveals a secreted form of the RARRES1 protein.Global secretome analysis identifies novel mediators of bone metastasis.Advances in the proteomic investigation of the cell secretome.Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma.The human secretome atlas initiative: implications in health and disease conditions.ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas Cell line with endogenous EGFRvIII expression is a suitable model for research and drug development purposes.Aligned chitosan-polycaprolactone polyblend nanofibers promote the migration of glioblastoma cells.Hematopoietic stem cells as a tool for the treatment of glioblastoma multiforme.Defective skeletal muscle growth in lamin A/C-deficient mice is rescued by loss of Lap2α.Semaphorin7A promotes tumor growth and exerts a pro-angiogenic effect in macrophages of mammary tumor-bearing mice Semaphorin7A: branching beyond axonal guidance and into immunity.Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.Towards developing biomarkers for glioblastoma multiforme: a proteomics view.Broader implications of SILAC-based proteomics for dissecting signaling dynamics in cancer.Quantitative proteomics using SILAC: Principles, applications, and developments.Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression.Microfluidic perfusion systems for secretion fingerprint analysis of pancreatic islets: applications, challenges and opportunities.Membrane proteome analysis of glioblastoma cell invasion.To the novel paradigm of proteome-based cell therapy of tumors: through comparative proteome mapping of tumor stem cells and tissue-specific stem cells of humans.Inflammatory cytokines, interleukin-1 beta and tumor necrosis factor-alpha, upregulated in glioblastoma multiforme, raise the levels of CRYAB in exosomes secreted by U373 glioma cells.Secretome analysis of Glioblastoma cell line--HNGC-2.Glucose induces rapid changes in the secretome of Saccharomyces cerevisiae Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology High-content analysis of tumour cell invasion in three-dimensional spheroid assays.Diamond, graphite, and graphene oxide nanoparticles decrease migration and invasiveness in glioblastoma cell lines by impairing extracellular adhesion Suppression of tumor-derived Semaphorin 7A and genetic ablation of host-derived Semaphorin 7A impairs tumor progression in a murine model of advanced breast carcinoma.

P2860

Q26799885-6154299E-5360-4DAE-9530-53E8AF00A561 Q28727517-41775508-47BC-42CC-B2D1-28DE25B695B8 Q30424028-C47C8CB7-E663-41DD-A85B-A4E3473E7474 Q30558835-332FA082-EE4C-4D4D-9A46-14991BB96DCB Q33762943-A6DA438A-D895-4746-B4D5-64CDA423E462 Q34303359-FA882B50-08DB-4D8F-B8F6-2471506F119F Q34437996-779683CA-59C7-4D8D-A015-F0E9AEAF25C5 Q34625129-00EFE7E8-E0D9-44B8-9634-ECFEEABAD90F Q34916522-A9A9594C-0BB3-4C54-A404-6574B5815C04 Q35052030-8EA0C8B4-8985-4F37-ABC3-515F4C83D561 Q35670456-FAB68A9E-4EC6-4041-AF74-B10CC6B3376B Q36049479-75389AAA-ABAB-4277-BD30-0D173C412953 Q36197438-2FA0E0DA-0109-4477-9714-3679E41B1819 Q36210409-3B3EFD85-787F-4707-ABCE-2D20C68D22DE Q36406560-96619361-5168-4B64-BF09-6AFA15E54608 Q36579481-BDF51F83-1572-4513-ADFE-07A114727D8A Q36602338-4E07DDBC-F617-4BEF-BD03-96AB6A248868 Q37126245-F367032F-EAF5-4192-B3DA-BC03241297F1 Q37286187-14075706-5598-44F3-BF2D-F2C100555691 Q37362563-F80FBE9B-CBBA-4F45-B93F-EAEEB2D54032 Q37384592-CBC3EEBA-710C-4C1B-BA49-F94B1C8EF889 Q37403493-EE9B1D1A-C66C-4EEF-897F-FFFDBB8F2020 Q37463359-CDB5D199-4D2C-4D14-ADE4-4D5279DA3A5F Q37555589-3D0BE633-3A3B-4310-A641-D2E04B4A70D5 Q37665093-C6768551-A38E-44FD-8845-09760F273455 Q38022543-86DC3D83-B497-4CCB-9E5C-976AD2F61041 Q38239173-F6C5DA7B-3EE6-4E60-A936-94532C176D2D Q38262764-FE6B06F7-EF22-41A2-88CE-3037772FE831 Q38533946-6EB22395-3938-4693-8710-23D94DF9110C Q38637324-45D8A92B-D2F6-4855-ABB2-5A640B84210D Q38687419-30909C53-31D9-4D09-BFE3-018D13A37307 Q38889754-3436687F-1C5E-4A82-A66D-995F7318F900 Q38949091-8B5B2E50-7CF3-40E5-BA79-FDF26648C65F Q38952817-1FF7B6AF-676A-411D-8D68-C38B5B543FDA Q39182040-94F97D0F-0797-4A71-B876-F0C7D4557303 Q41962920-43A87626-E034-49DE-A922-3871E8E4CF85 Q42284739-C4062460-5AEE-4CBF-8DA4-19D8E71ADF7D Q42353637-AB4B3287-825D-409A-BF4E-51EDB4A1EA2A Q42373821-0B921D58-4F0B-46C8-82F1-82315E71A769 Q42378295-5F877F95-0C97-479F-8794-0F1B7635F765

P2860

Secretome signature of invasive glioblastoma multiforme

http://www.wikidata.org/entity/Q33901250

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Secretome signature of invasive glioblastoma multiforme

@ast

Secretome signature of invasive glioblastoma multiforme

@en

type

label

Secretome signature of invasive glioblastoma multiforme

@ast

Secretome signature of invasive glioblastoma multiforme

@en

prefLabel

Secretome signature of invasive glioblastoma multiforme

@ast

Secretome signature of invasive glioblastoma multiforme

@en

P1433

Q33901250-AFBED934-CF1F-49FE-81DC-F3563F5EFF40

P1476

Q33901250-52F244AF-6B86-4872-8B5D-AF763B7EEF7F

P2093

Q33901250-17C919F0-0916-474B-9737-E1A8D3B9913F

Q33901250-38932E01-5C89-4B4D-9085-46508E51E87E

Q33901250-3C63232E-B1C7-4232-BFF5-458280980881

Q33901250-5A0A5EB7-B812-4AD0-A94C-9EE7422340D2

Q33901250-80339B4C-2E0A-481D-B971-4E882217D9B9

P2860

Q33901250-07D05665-3105-48DF-953A-8FF46B90CD1F

Q33901250-085C7562-1EBE-413F-8F03-2F0F183DDD86

Q33901250-0D663E9F-FCCD-4B5C-A71F-60A8C306A7CB

Q33901250-112D6F90-EF6E-4253-93EA-2DFADBBCA670

Q33901250-114C2ACE-AF62-4767-9228-8BC2F812F82B

Q33901250-155049EF-7ACB-45F0-A6D3-8573DA2072CC

Q33901250-156781F1-6DF0-4356-99B7-302F212F627C

Q33901250-197850C8-3677-4819-BFCD-6D538AF33B43

Q33901250-1AD87B82-A65F-478D-A16E-D37DC168C37B

Q33901250-20A940E3-C5BD-4045-9942-A6D01EBEEF86

P304

Q33901250-7782AB0F-C2B3-4FD8-BE92-B269159435B9

P31

Q33901250-6CDB7449-AEF1-4ABD-B162-EDDCFED27797

P356

Q33901250-AA627B61-10A0-452F-9BFC-AE63C036D892

P433

Q33901250-9E3F88B3-9260-4B4C-B68C-EAC26C9EDD12

P478

Q33901250-2AFDEFFE-17BC-4CF6-987F-A59487DA5203

P50

Q33901250-771F57AC-1974-41A6-B731-7D7281E4B748

P577

Q33901250-6205051A-A27B-4C73-8F76-71253D856476

P5875

Q33901250-3C8EF7C6-2388-45AA-91D9-DBFC2FAD9B57

P698

Q33901250-8A5CD8CE-3948-4866-BBC2-CE94A5E418EF

P932

Q33901250-7FEC6D75-7621-4E39-B590-7500FD29664C

P356

P1433

Journal of Proteome Research

P1476

Secretome signature of invasive glioblastoma multiforme

@en

P2093

Catherine A Formolo

http://www.w3.org/2001/XMLSchema#string

Norman H Lee

http://www.w3.org/2001/XMLSchema#string

Russell Williams

http://www.w3.org/2001/XMLSchema#string

Tobey J MacDonald

http://www.w3.org/2001/XMLSchema#string

Yetrib Hathout

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropilin is a receptor for the axonal chemorepellent Semaphorin III

Neuropilin is a semaphorin III receptor

Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I

Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period

Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression

Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity

Analysis of strain and regional variation in gene expression in mouse brain

Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics

P304

3149-3159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/PR200210W

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Heather Gordish-Dressman

P577

2011-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51129042

http://www.w3.org/2001/XMLSchema#string

P698

21574646

http://www.w3.org/2001/XMLSchema#string

P932

3136381

http://www.w3.org/2001/XMLSchema#string